Skip to content

Operating Income at other companies

Hooker Furnishings Corporation logo
Hooker Furnishings CorporationHOFT
$1.58M+417%
Agrify Corporation logo
Agrify CorporationRYM
-$4.03M-9.0%
Solidion Technology, Inc. logo
Solidion Technology, Inc.STI
-$1.77M+43.4%
Spectral AI, Inc. logo
Spectral AI, Inc.MDAI
-$1.97M-120%
ROC
Rank One Computing ROC
-$3.02M-196%
Richtech Robotics Inc. logo
Richtech Robotics Inc.RR
-$11.81M-203%

Segments

By segment

See full
Specialty Surgery$88.87M
Tissue Reconstruction$18.94M

Other financials

Income statement

See full
Revenue$418.8M+0.8%
Gross profit$219.7M+5.0%
Operating income$19.3M+104%
Net income$4.5M+101%
EPS (diluted)$0.06+101%

Balance sheet

See full
Cash & equivalents$214.4M-1.6%
Total debt$2.0B+3.2%
Total equity$1.0B+0.5%
Total assets$3.6B-2.8%

Cash flow

See full
Operating cash flow$22.8M+156%
CapEx$12.3M-38.9%
Free cash flow$10.5M+193%

Valuation

See full
Market cap$1.52B+49.2%
Enterprise value$3.27B+20.9%
P/S0.9×+0.3×

Profitability

See full
Gross margin52.5%-0.1pp
Operating margin2.6%+1.3pp
Net margin-0.4%
FCF margin3.8%-6.3pp

Returns & leverage

See full
Return on equity-0.7%
Debt / equity1.9×+0.1×
Current ratio3.6×+2.4×

Where this comes from

Reported directly by Integra LifeSciences in its filing.

Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.

The official record: Integra LifeSciences’s 10-Q, filed July 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Integra LifeSciences's operating income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Integra LifeSciences's operating income?
Integra LifeSciences (IART) reported operating income of $19.29M in Q2 2026.
How has Integra LifeSciences's operating income changed year-over-year?
Integra LifeSciences's operating income increased by 103.8% year-over-year, from -$512.67M to $19.29M.
What is the long-term trend for Integra LifeSciences's operating income?
Over 4 years (2021 to 2025), Integra LifeSciences's operating income has grown at a 27.2% compound annual growth rate (CAGR), from $197.23M to -$516.41M.